Elevate your NGS capabilities with Seqera Platform
With Seqera Platform you can enhance your data analysis capabilities, and achieve better results for genomics, specifically for NGS-based testing for cancer patients. Additionally, it allows you to collaborate with scientists across the globe, and scale your NGS pipelines to international markets.
We have several companies working on cancer testing like Genomics England or Denmark NGC, as well as cancer research like Gristone.Tower is the advanced solution that Pfizer need to take their Next-Generation Sequencing-Based Testing to the next level. Our platform provides you with all the tools you need to streamline your NGS workflows and boost analysis capabilities.
Pfizer, bring your NGS-based testing to the next level Receive a personalized demo
Form not loading? Check your browser security settings, or try a different browser. If the problem persists, please contact marketing@seqera.io.
Data pipelines into the clouds & beyond
-
Improve productivity
With a unified view over your data, pipelines, results, and compute resources.
Streamline your research workflows and accelerate scientific discovery. Simplify your analysis process, from data generation to external reporting, and optimize your pipeline management.
-
Reduce costs
Optimise compute and storage costs, reduce expensive errors and manage spend across projects and teams.
Seqera Platform has demonstrated cost savings of up to 85% running large-scale sequencing workflows.
-
Remove complexity
So that users can focus on the science that matters, and not on infrastructure engineering.
-
Simplify compliance
Ensure compliance and security with reliable, predictable, reproducible, and auditable pipeline execution.
Production Proven at Scale
Today Nextflow and Seqera Platform are used by multiple research organizations and public health authorities to perform large-scale genomic analysis and testing in their choice of clouds. Applications include cancer screening, population-level studies, pathogenic surveillance, clinical analysis, and screening for a wide variety of other diseases and medical conditions, including Ebola, Yellow Fever, and Zika.
Nextflow and Seqera Platform users include the Johnson & Johnson, Invitae, and Genomics England, where custom pipelines such as the Small Variant workflow are used to aid in rare disease and cancer screening. Nextflow proved its effectiveness during the recent pandemic by enabling organizations such as the COVID-19 Genomics UK Consortium and other public health authorities to easily share pipelines and scale analysis capacity rapidly. In addition to supporting scalable testing and analysis, Nextflow is also used in research and clinical settings. For example, Gritstone oncology uses Seqera Platform to support a variety of machine learning and analysis pipelines used in the development of targeted immunotherapies.
Part of the attraction of Seqera Platform is that users can instantly access high-quality nf-core pipelines suitable for various fields, including pipelines for detecting germline or somatic variants helpful in oncology. Organizations can also adapt their own analysis pipelines to Tower, where they can effectively scale analysis or leverage over 900 off-the-shelf nf-core modules to accelerate the development of their customized analysis pipelines.